Jci_page_head_homepage_01 Jci_page_head_homepage_02
Linda Koch, F. Thomas Wunderlich, Jost Seibler, A. Christine Könner, Brigitte Hampel, Sigrid Irlenbusch, Georg Brabant, C. Ronald Kahn, Frieder Schwenk, Jens C. Brüning
Published in Volume 118, Issue 6
J Clin Invest. 2008; 118(6):2132–2147 doi:10.1172/JCI31073
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0831073
Figure 1
Generation of IRΔper mice.

(A) General scheme of the inducible peripheral IR knockout mouse strain. Mice expressing a CreERT2 fusion protein under the control of the Rosa26 promoter were crossed with mice homozygous for the floxed IR allele. Binding of tamoxifen (T) to the mutated ligand binding domain of the ER (ERLBD) promotes a nuclear import of the fusion protein and results in the excision of exon 4 by the Cre recombinase. (B) Genomic map of the mouse IR locus surrounding exon 4. Location of the probe used for Southern blot analysis is indicated by black bars. NcoI, restriction enzyme sites; 4, exon 4 of the IR gene; 2.5 kb, size of floxed allele band; 5 kb, size of deleted allele band. (C) Southern blot analysis of IR deletion in whole brain, heart, skeletal muscle, liver, pancreas, and WAT of 12-week-old IRΔper mice over a period of 12 days. Day 1, beginning of tamoxifen treatment; Δ, 5-kb band of the deleted allele; flox, 2.5-kb band of the floxed allele. (D) Western blot analysis of IR and AKT (loading control) in whole brain, heart, skeletal muscle, liver, pancreas, and WAT of tamoxifen-treated 13-week-old IRΔper mice and control mice over a period of 24 days. Day 1, beginning of tamoxifen feeding.